abstract |
The invention provides N- (4- (7-azabicyclo [2.2.1] heptan-7-yl) -2- (trifluoromethyl) phenyl) -4-oxo-5- (trifluoromethyl) -1 And solid form of, 4-dihydroquinoline-3-carboxamide, such as crystalline form, pharmaceutical compositions thereof and methods of using the same. |